Search

Search Results

##search.searchResults.foundPlural##

Increased plasma lipocalin-2 levels correlate with disease severity and may be a marker of acute inflammatory response in patients with psoriasis

Chuyen Thi Hong Nguyen, Oanh Phan Tram Nguyen

21-11-2022

https://doi.org/10.4081/dr.2022.9469

1137

PDF: 447

HTML: 27
Treatment satisfaction among patients with psoriasis in Saudi Arabia

Mahdi Aldhafiri, Rahaf Almutairi, Reem Albejais, Asma Almubark, Hussain Alwesaibie, Mohammed Albesher, Manayer Almustihi

15-04-2024

https://doi.org/10.4081/dr.2024.9967

783

PDF: 410

HTML: 15
Real-world use of dimethyl fumarate in patients with plaque psoriasis: a Delphi-based expert consensus

Martina Burlando, Elena Campione, Aldo Cuccia, Giovanna Malara, Luigi Naldi, Francesca Prignano, Leonardo Zichichi

29-12-2022

https://doi.org/10.4081/dr.2023.9613

1592

PDF: 425

HTML: 70
Anti-interleukin-17 and anti-interleukin-23 biologic drugs for genital psoriasis: a single-center retrospective comparative study

Andrea Cortese, Luigi Gargiulo, Luciano Ibba, Giovanni Fiorillo, Francesco Toso, Carlo Alberto Vignoli, Alessandra Narcisi, Antonio Costanzo, Mario Valenti

19-05-2023

https://doi.org/10.4081/dr.2023.9692

896

PDF: 447

HTML: 15
A characterization of the expression of 14-3-3 isoforms in psoriasis, basal cell carcinoma, atopic dermatitis and contact dermatitis

Line Raaby, Kristian Otkjær, Maria Luise Salvskov-Iversen, Claus Johansen, Lars Iversen

e14

14-10-2010

https://doi.org/10.4081/dr.2010.e14

3934

PDF: 739

HTML: 320
Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as inflammatory markers in psoriasis: a case-control study

Hao Trong Nguyen, Long Dinh Hoang Vo, Nguyen Nhat Pham

14-07-2022

https://doi.org/10.4081/dr.2022.9516

1405

PDF: 573

HTML: 15
Natural language processing of online support group postings reveals patients’ perspectives on strategies for managing psoriasis

Karan Rajalingam, Phillip M. Johansen, Nicole J. Levin, Jerry Qi, Oge Marques

11-09-2023

https://doi.org/10.4081/dr.2023.9824

739

PDF: 414

HTML: 19
Erythrodermic psoriasis improved by tildrakizumab

Giampaolo Trevisan, Lerica Germi, Luigi Naldi

23-11-2022

https://doi.org/10.4081/dr.2022.9448

957

PDF: 521

HTML: 18
A study on tumor necrosis factor-α single nucleotide polymorphisms and psoriasis vulgaris in Vietnam

Vinh Ngo Minh, Thiên Phúc Lý, Hao Nguyen Trong, Chuong Nguyen Hoang

12-04-2024

https://doi.org/10.4081/dr.2024.9899

823

PDF: 470

HTML: 17
Bacterial colonization of psoriasis plaques. Is it relevant?

Eva Marcus, Diana Demmler, Andreas Rudolph, Matthias Fischer

e14

05-08-2011

https://doi.org/10.4081/dr.2011.e14

1537

PDF: 682

HTML: 621
Infliximab-induced intertriginous psoriasis in patient with Crohn's desease

Federica Mola, Alberico Motolese

e40

03-10-2011

https://doi.org/10.4081/dr.2011.e40

1161

PDF: 531

HTML: 1070
Erythrodermic psoriasis treated with apremilast

John Arcilla, Daniel Joe, Johnathan Kim, Yohanan Kim, VuAnh N. Truong, Navin Jaipaul

19-09-2016

https://doi.org/10.4081/dr.2016.6599

1923

PDF: 865

HTML: 597
Late reaction to ustekinumab infusion

Marina Resener Morais, Luana Pizarro Meneghello, Carina Flores de Oliveira, André Vicente Esteves Carvalho

e2

09-09-2013

https://doi.org/10.4081/dr.2013.e2

3812

PDF: 588

HTML: 259
Real-world treatment patterns, patient-reported outcomes, and effectiveness of flexible-dosing etanercept in patients with plaque psoriasis in Greece

Dimitris Rigopoulos, Aikaterini Patsatsi, Christina Antoniou, Dimitrios Sotiriadis, Angeliki Roussaki-Schulze, Nadia Boubouchairopoulou, Ioannis Skiadas, Vasillios Tsekouras, Ana Cristina Hernandez Daly

21-11-2022

https://doi.org/10.4081/dr.2022.9265

1387

PDF: 355

HTML: 20
Long term efficacy, safety, and tolerability of tildrakizumab in epileptic patient with psoriasis and eczema

Nicoletta Bernardini, Nevena Skroza, Giovanni Rossi, Alessandra Mambrin, Ersilia Tolino, Federica Marraffa, Martina Caviglia, Antonio Di Guardo, Salvatore Volpe, Ilaria Proietti, Concetta Potenza

21-11-2022

https://doi.org/10.4081/dr.2022.9447

1166

PDF: 335

HTML: 38
Guselkumab for the treatment of severe plaque psoriasis in a schizophrenia patient

Nicoletta Bernardini, Nevena Skroza, Elisabeth Prevete, Federica Marraffa, Ilaria Proietti, Ersilia Tolino, Alessandra Mambrin, Giovanni Rossi, Salvatore Volpe, Giuseppe Bersani, Concetta Potenza

23-11-2022

https://doi.org/10.4081/dr.2022.9476

1225

PDF: 395

HTML: 23
Lentiginous eruption in resolving psoriasis plaques during treatment with ixekizumab: a case report and review of the literature

Pablo Santa María, Fernando Valenzuela, Claudia Morales, Raul De la Fuente, Roberto Cullen

11-10-2017

https://doi.org/10.4081/dr.2017.7079

1218

PDF: 575

HTML: 137
A severe psoriasis flare after COVID-19 treated with risankizumab: complete skin clearance after 16 weeks

Luciano Ibba, Luigi Gargiulo, Giulia Pavia, Alessandra Narcisi, Antonio Costanzo, Mario Valenti

06-06-2023

https://doi.org/10.4081/dr.2023.9722

632

PDF: 361

HTML: 11
A case of squamous cell carcinoma arising in a giant porokeratosis previously diagnosed as psoriasis

Lorry Aitkens, Joel Byrne, Charay Jennings-Dover, Kathryn Anne Potter

29-12-2022

https://doi.org/10.4081/dr.2023.9634

802

PDF: 371

HTML: 102
Biologics and small molecules treatment for moderate-to-severe atopic dermatitis patients with comorbid conditions and special populations: an Italian perspective

Alba Guglielmo, Maria Ludovica Deotto , Luigi Naldi , Giuseppe Stinco, Alessandro Pileri, Bianca Maria Piraccini, Anna Belloni Fortina, Andrea Sechi

13-09-2023

https://doi.org/10.4081/dr.2023.9839

2187

PDF: 810

HTML: 22
Narrowband UVB-induced lichen planus pemphigoides

Wai Man Mandy Chan, Joyce Siong See Lee, Colin Seng Thiam Theng, Sze Hon Chua, Hazel Hwee Boon Oon

e43

25-10-2011

https://doi.org/10.4081/dr.2011.e43

2602

PDF: 747

HTML: 1345
Two episodes of cutaneous non-tuberculous mycobacterial infection in a patient with psoriasis

Wai Sze Agnes Chan, Shang-Ian Tee, Nisha Su Yien Chandran, Jiun Yit Pan

15-06-2015

https://doi.org/10.4081/dr.2015.5712

1801

PDF: 738

HTML: 771
Cost analysis in the management of moderate-to-severe psoriasis: comparison between conventional and biological systemic therapies

Edoardo Mortato, Silvia Baratta, Luca Rubino, Anna Paola De Caro, Francesco Loconsole

19-06-2023

https://doi.org/10.4081/dr.2023.9755

713

PDF: 322

HTML: 9
Early morphea simulating patch-stage mycosis fungoides in two cases

Hamid R. Ghasemi Basir, Pedram Alirezaei, Aliasghar Rezanejad, Sajjad Daneshyar

23-04-2018

https://doi.org/10.4081/dr.2018.7477

1322

PDF: 610

HTML: 120
Prevalence and association of renal disorders in Saudi adult patients with psoriasis and psoriatic arthritis: a tertiary-center retrospective cross-sectional study

Mishari Alrubaiaan, Abdullah Alhobabi, Raghad Alharthi, Saad Alsulaiman, Abdullah Altasan, Ibrahim Momen, Mohammad Almohideb

02-01-2025

https://doi.org/10.4081/dr.2025.10083

301

PDF: 136

1 - 25 of 37 items 1 2 > >>

Search

Search Results

Increased plasma lipocalin-2 levels correlate with disease severity and may be a marker of acute inflammatory response in patients with psoriasis

Treatment satisfaction among patients with psoriasis in Saudi Arabia

Real-world use of dimethyl fumarate in patients with plaque psoriasis: a Delphi-based expert consensus

Anti-interleukin-17 and anti-interleukin-23 biologic drugs for genital psoriasis: a single-center retrospective comparative study

A characterization of the expression of 14-3-3 isoforms in psoriasis, basal cell carcinoma, atopic dermatitis and contact dermatitis

Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as inflammatory markers in psoriasis: a case-control study

Natural language processing of online support group postings reveals patients’ perspectives on strategies for managing psoriasis

Erythrodermic psoriasis improved by tildrakizumab

A study on tumor necrosis factor-α single nucleotide polymorphisms and psoriasis vulgaris in Vietnam

Bacterial colonization of psoriasis plaques. Is it relevant?

Infliximab-induced intertriginous psoriasis in patient with Crohn's desease

Erythrodermic psoriasis treated with apremilast

Late reaction to ustekinumab infusion

Real-world treatment patterns, patient-reported outcomes, and effectiveness of flexible-dosing etanercept in patients with plaque psoriasis in Greece

Long term efficacy, safety, and tolerability of tildrakizumab in epileptic patient with psoriasis and eczema

Guselkumab for the treatment of severe plaque psoriasis in a schizophrenia patient

Lentiginous eruption in resolving psoriasis plaques during treatment with ixekizumab: a case report and review of the literature

A severe psoriasis flare after COVID-19 treated with risankizumab: complete skin clearance after 16 weeks

A case of squamous cell carcinoma arising in a giant porokeratosis previously diagnosed as psoriasis

Biologics and small molecules treatment for moderate-to-severe atopic dermatitis patients with comorbid conditions and special populations: an Italian perspective

Narrowband UVB-induced lichen planus pemphigoides

Two episodes of cutaneous non-tuberculous mycobacterial infection in a patient with psoriasis

Cost analysis in the management of moderate-to-severe psoriasis: comparison between conventional and biological systemic therapies

Early morphea simulating patch-stage mycosis fungoides in two cases

Prevalence and association of renal disorders in Saudi adult patients with psoriasis and psoriatic arthritis: a tertiary-center retrospective cross-sectional study

authors

reviewers

indexing

dermatopathology

Keywords